This section presents information about the death rate statistics
for the various types of Lung conditions.
Disease | Death Rate Estimate | US deaths estimate | Statistic Used for Calculation |
| Pneumonia |
unavailable |
|
No information
|
| Lung cancer |
unavailable |
|
No information
|
| Bronchopulmonary dysplasia |
unavailable |
|
No information
|
| Bronchitis |
N/A |
N/A |
No information
|
| Chronic Bronchitis |
approx 1 in 22 or 4.45% or 12.1 million people in USA |
12.1 million Americans (NHLBI) |
12.1 million Americans (NHLBI)
|
| Emphysema |
approx 1 in 136 or 0.74% or 2 million people in USA |
2 million Americans (NHLBI); 17 per 1000 - NHIS95; 2 million annually |
2 million Americans (NHLBI); 17 per 1000 - NHIS95; 2 million annually
|
| COPD |
approx 1 in 20 or 4.96% or 13.5 million people in USA |
13.5 million Americans (NHLBI) |
13.5 million Americans (NHLBI)
|
| Cystic fibrosis |
approx 1 in 31,000 or 0.00% or 8,774 people in USA |
1 per 31,000 Asian American newborns suffer from cystic fibrosis in the US, genetics Home Reference website |
1 per 31,000 Asian American newborns suffer from cystic fibrosis in the US, genetics Home Reference website
|
| bronchiectasis |
unavailable |
|
No information
|
| Asthma |
approx 1 in 15 or 6.40% or 17.4 million people in USA |
6.4% USA (NIAID); 17 million Americans (NIAID) including 5 million children; 8.1 million children (NHIS-97), 51 per 1000 - NHIS95; 14.5 million; 5% of population (NWHIC); 14.9 million in 1995 (NHLBI) |
6.4% USA (NIAID); 17 million Americans (NIAID) including 5 million children; 8.1 million children (NHIS-97), 51 per 1000 - NHIS95; 14.5 million; 5% of population (NWHIC); 14.9 million in 1995 (NHLBI)
|
| bronchiolitis |
N/A |
N/A |
No information
|
| bronchiolitis obliterans |
N/A |
N/A |
No information
|
| Interstitial lung diseases |
N/A |
N/A |
No information
|
| Sarcoidosis |
approx 1 in 5,000 or 0.02% or 54,400 people in USA |
20 per 100,000 overall; 5 in 100,000 white people; 40 out of 100,000 black people; Scandinavia 64 out of 100,000 people |
20 per 100,000 overall; 5 in 100,000 white people; 40 out of 100,000 black people; Scandinavia 64 out of 100,000 people
|
| pulmonary fibrosis |
N/A |
N/A |
No information
|
| Bronchial disorders |
N/A |
N/A |
No information
|
| Allergic bronchopulmonary aspergillosis |
N/A |
N/A |
No information
|
| Anthrax |
N/A |
N/A |
No information
|
| Chlamydia pneumoniae |
N/A |
N/A |
No information
|
| Diphtheria |
N/A |
N/A |
No information
|
| Drowning |
unavailable |
|
No information
|
| Familial emphysema |
N/A |
N/A |
70,000 Americans
|
| High altitude pulmonary edema |
N/A |
N/A |
No information
|
| Lung abscess |
N/A |
N/A |
No information
|
| Lymphangioleiomyomatosis |
N/A |
N/A |
Several hundred people in the USA (NHLBI)
|
| Mesothelioma |
N/A |
N/A |
No information
|
| Mountain sickness |
N/A |
N/A |
No information
|
| Pleural effusion |
N/A |
N/A |
No information
|
| Pleurisy |
N/A |
N/A |
No information
|
| Pneumococcal pneumonia |
unavailable |
|
No information
|
| Pneumonitis |
unavailable |
|
No information
|
| Primary pulmonary hypertension |
N/A |
N/A |
No information
|
| Pulmonary Anthrax |
N/A |
N/A |
No information
|
| Respiratory conditions |
approx 1 in 1 or 78.90% or 214.6 million people in USA |
78.9 per 100 (NHIS96) |
78.9 per 100 (NHIS96)
|
| Respiratory diphtheria |
N/A |
N/A |
No information
|
| Respiratory infections |
N/A |
N/A |
No information
|
| Respiratory syncytial virus |
N/A |
N/A |
No information
|
| Silicosis |
unavailable |
|
No information
|
| Stridor |
N/A |
N/A |
No information
|
| Suffocation |
unavailable |
|
No information
|
| Tuberculosis |
unavailable |
|
No information
|
| Wheezing |
N/A |
N/A |
No information
|
| Flu |
unavailable |
|
No information
|
| Parainfluenza |
N/A |
N/A |
No information
|
| Respiratory failure |
unavailable |
|
No information
|
| Pulmonary hypertension |
N/A |
N/A |
No information
|
| Pulmonary edema |
unavailable |
|
No information
|
| Pulmonary embolism |
unavailable |
|
No information
|
| Pulmonary thromboembolism |
unavailable |
|
No information
|
| Adult respiratory distress syndrome |
unavailable |
|
No information
|
| Respiratory distress syndrome |
approx 1 in 6,800 or 0.01% or 40,000 people in USA |
40,000 infants and 150,000 adults with adult RDS (NHLBI) |
40,000 infants and 150,000 adults with adult RDS (NHLBI)
|
| Idiopathic Pulmonary Fibrosis |
N/A |
N/A |
No information
|
| pneumothorax |
N/A |
N/A |
No information
|
| collapsed lung |
N/A |
N/A |
No information
|
| pneumoconiosis |
unavailable |
|
No information
|
| Acute Bronchitis |
unavailable |
|
No information
|
| Goodpasture syndrome |
N/A |
N/A |
rare.
|
New therapies are improving the survival rates for patients with lung cancer. How do these treatments work?
There are many treatments options available for both small cell and non-small cell lung cancer including surgery, radiation and chemotherapy. Find...
Lung Cancer, the leading cause of cancer death for both men and women in the US, will be diagnosed in over 169,000 people this year. Avoiding tobacco...
Surgery and radiation are the standard treatments for early-stage lung cancer. Now there's evidence chemotherapy may have a role, too. Listen as...
See full list of 10 related videos
